Senseonics Holdings (SENS) Net Cash Flow Growth (1y) (2015 - 2026)
Senseonics Holdings (SENS) Net Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.15 Bn | 176.85 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.85 Bn | 125.98 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.66 Bn | 67.21 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.18 Bn | 2.07 Bn | 76.43% |
| 10 | Senseonics Holdings | 230.49 Mn | 166.17 Mn | 6.94 Mn | 69.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.90% |
| Dec 31, 2025 | -87.84% |
| Sep 30, 2025 | 137.94% |
| Jun 30, 2025 | 86.01% |
| Mar 31, 2025 | -332.90% |
| Dec 31, 2024 | 138.05% |
| Sep 30, 2024 | -128.48% |
| Jun 30, 2024 | -236.82% |
| Mar 31, 2024 | 63.05% |
| Dec 31, 2023 | 6,356.31% |
| Sep 30, 2023 | 373.69% |
| Jun 30, 2023 | -357.78% |
| Mar 31, 2023 | 67.42% |
| Dec 31, 2022 | 102.42% |
| Sep 30, 2022 | 57.78% |
| Jun 30, 2022 | 105.89% |
| Mar 31, 2022 | -96.54% |
| Dec 31, 2021 | -55.73% |
| Sep 30, 2021 | -590.99% |
| Jun 30, 2021 | -3,998.85% |